C81.92
Hodgkin lymphoma, unspecified, intrathoracic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Hodgkin lymphoma, classified under ICD-10 code C81.92, is a type of lymphatic system cancer that primarily affects the lymph nodes within the chest. This disease, also known as Hodgkin disease, is characterized by abnormal growth of lymphocytes, a type of white blood cell responsible for immune response. While Hodgkin lymphoma can develop in various parts of the body, this specific code refers to cases where the disease is localized to the intrathoracic (within the chest) lymph nodes. Understanding this condition helps in grasping its implications, symptoms, causes, and available diagnostic and treatment options.
Causes & Symptoms
Clinical Causes: Genetic factors: A family history of Hodgkin lymphoma may increase risk. Viral infections: Infection with viruses like Epstein-Barr virus (EBV) has been associated with the development of Hodgkin lymphoma. Immune system deficiencies: Conditions that weaken the immune system, such as HIV/AIDS, can raise susceptibility. Environmental exposures: Exposure to certain chemicals or toxins in the environment may contribute to risk, though evidence remains inconclusive. Age and gender: It most commonly occurs in young adults aged 15-35 and older adults over 55, with a slightly higher prevalence in males.
Key Symptoms: Painless swelling of lymph nodes in the neck, armpits, or chest Persistent cough or chest pain due to enlarged lymph nodes pressing on airways or other structures Unexplained weight loss Fever that comes and goes Night sweats Fatigue or general feelings of tiredness Itching all over the body Shortness of breath if lymph nodes in the chest cause airway obstruction
Diagnostic & Treatment
Diagnosis Path: The process of diagnosing Hodgkin lymphoma generally includes a combination of clinical evaluation, imaging tests, and biopsy procedures. Initial assessments involve physical examinations to identify swollen lymph nodes and review symptoms. Imaging techniques such as chest X-rays, computed tomography (CT) scans, or positron emission tomography (PET) scans help visualize the location and extent of lymph node involvement within the chest. Confirmatory diagnosis requires a biopsy of the affected lymph node, where a pathologist identifies characteristic Reed-Sternberg cells, which are indicative of Hodgkin lymphoma. Additional laboratory tests may include blood tests to evaluate immune status and organ function. Staging determines how far the disease has spread, guiding treatment options.
Treatment Protocols: Treatment approaches for Hodgkin lymphoma vary depending on the stage and specific characteristics of the disease. Common options include:
Clinical Advice & FAQs
Billing Guidance
Is C81.92 a billable ICD-10 code?
Yes, C81.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.92?
Clinical documentation must specify the nature of Hodgkin lymphoma, unspecified, intrathoracic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference